Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Akeso
Related studies linked through entity extraction aliases.
A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of AK117 (Anti-CD47) in Patients With Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of AK112 in the Treatment of Advanced Gynecological Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Dose Escalation and Expansion Study of AK117
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Alone or in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of AK104 Plus Anlotinib in NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of AK112 for Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of AK119 (Anti-CD73) in Combination With AK104 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1